Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
NCT00868959
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
817
Enrollment
INDUSTRY
Sponsor class
Conditions
Bipolar Depression
Interventions
DRUG:
lurasidone
Sponsor
Sumitomo Pharma America, Inc.